期刊文献+

急性髓性白血病LRP、Pg-p和MRP表达与多药耐药分型及临床研究

The study of clinical significance and type of lung resistance-related protein, P-glycoprotein and multidrug resistance-associated protein expression in acute myelogenous leukemia
下载PDF
导出
摘要 目的 研究肺耐药相关蛋白 (LRP)、P糖蛋白 (Pg - p)和多药耐药相关蛋白 (MRP)表达与急性髓性白血病 (AML)患者多药耐药 (MDR)的关系及其临床意义。方法 将 12 9例AML患者分为初治组和复发难治组 ,用免疫组化法检测患者骨髓或外周血单个核细胞中LRP、Pg -p和MRP表达。根据上述三种蛋白的表达情况将LRP或Pg - p或MRP单一表达阳性者定为 :“单纯型” ;将LRP或Pg - p或MRP两项以上阳性者定为 :“混合型” ,观察这种分型与临床疗效的关系。同时用MTT技术观察了白血病细胞对柔红霉素 (DNR)的敏感性。结果 在AML初治组中耐药蛋白表达阴性者的完全缓解 (CR)率 75 .6 % ,而耐药蛋白表达阳性者CR率 2 0 .8% (“单纯型”2 1.1% ,“混合型”2 0 % ) ;在AML复发及难治组中 ,耐药蛋白表达为“混合型”者CR率 15 .4 % ,耐药蛋白表达为“单纯型”者CR率 2 9.6 % ,“混合型”CR率低于“单纯型”。结论 LRP、Pg -p和MRP均与耐药有关 ,这种“混合型”和“单纯型”耐药分类法 。 Objective: To evaluate the relationship between lung resistance-related protein( LRP), multidrug resistance-associated protein (MRP), P-glycoprotein(Pg-p) and multidrug resistance in acute myelogenous lukemia (AML). Methods 129 AML patients were divided into tow groups: untreated and relapsed/refractory. The expression of LRP、Pg-p and MRP was detected with immunohistochemistry .Only one positive expression of LRP,Pg-p or MRP was entitled“single type'while two or three positive expression of LRP,Pg-p and MRP was entitled “composite type'. In same time the chemosensitivity of leukemia cells to DNR was estimated by MTT assay. Results In untreated group, complete remission (CR) rate was 75.6% in negative expression of LRP,Pg-p and MRP while it was 20.8% in positive expression of LRP,Pg-p and MRP(“single type'21.1%,“composite type'20%).In relapsed/refractory group,CR rate was 15.4% in “composite type' group while it was 29.6% in “single type' group.CR rate of “composite type' group was lower than“single type' group. Conclusion Overexpression of one or more protein of LRP,Pg-p and MRP is associated with MDR in AML. Expression of LRP, Pg-p and MRP is good indicators in clinical effect of AML . Two or three factors of LRP, Pg-p and MRP are more valuable in the evaluation of MDR than any one of these three factors.
出处 《泰山医学院学报》 CAS 2004年第5期421-424,共4页 Journal of Taishan Medical College
关键词 LRP 表达 单纯型 耐药蛋白 AML 急性髓性白血病 阳性 CR 混合型 研究 Leukemia Multidrug resistance P-glycoprotein Lung resistance-related protein Multidrug resisitance-associated protein
  • 相关文献

参考文献9

  • 1Hiddemonn W, Martin WR, Sauerland CM, et al. Definition of refractoriness against covention chemotherapy in AML-a prosposal based on the result of retreatment by thioguanine,cytosine arabinoside and daunorubicin(TAD9) in 150 patiens with relapse after standardized first line therap[J]. Leukemia,1990,4:184. 被引量:1
  • 2罗梅华,卞寿庚,冯敏,孟庆祥,秘营昌,赵春亭,王冬梅,吴克复.药敏试验MTT法对急性白血病化疗疗效的预示价值[J].中国实验血液学杂志,1995,3(1):57-61. 被引量:17
  • 3张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 4沈绍华,叶欣,陈力军.肺耐药相关蛋白与多药耐药关系的研究现状[J].国外医学(肿瘤学分册),2000,27(4):230-232. 被引量:4
  • 5Michieli M, Damiani D, Ermacora A, et al. P-glycoprotein( PGP) and lung resistance- related protein( LRP) expression and function in Leukaemic blast cells[J]. British Journal of Haematology,1997,96:356-365. 被引量:1
  • 6Michieli M, Michelutti A, Damiani D, et al. Amifostine does not inhibit the toxic effects of anthracycline derivates or mitoxantrone on MDR tumor cell lines[J]. Leuk Lymphoma, 2001,42(4):721-729. 被引量:1
  • 7Slovak ML, Ho JP, Cole SP, et al. The LRP gene encoding a major vault protein with drug associated maps proximal to MRP on chromosome 16:evidence that chromosome breakage plays a key role in MRP or LRP gene amplification[J]. Cancer Res, 1995,554214-9. 被引量:1
  • 8Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M(r)110 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance[J]. Cancer Res,1993,53:1475-81. 被引量:1
  • 9List AF, Spier CS, Grogan TM, et al. Overexpression of the major vault transporter protein lung- resistance protein predicts treatment outcome in AML[J]. Blood,1996,87:2464-9. 被引量:1

二级参考文献9

  • 1Weisenthal LM,Lippmam ME.Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treatment Reports . 1985 被引量:1
  • 2Mosmann T.Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. Journal of Immunological Methods . 1983 被引量:1
  • 3Carmichael J,DeGraff G,Gazdar AF,et al.Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research . 1987 被引量:1
  • 4Alley MC,Scudiero DA,Monks A,et al.Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research . 1988 被引量:2
  • 5Hwang W-S,Chen L-M,Huang S-H,et al.Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. Leukemia Research . 1993 被引量:1
  • 6Preisler HD,Raza A,Larson R,et al.Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a reviow of three consecutive trials of the treatment of poor prognosis patients. Leukemia Research . 1991 被引量:1
  • 7Preisler HD,Raza A.Cell cycle studies in acute myelogenous leukemia. Leukemia . 1992 被引量:1
  • 8Von Hoff D D.In vitro predictive testing: the sulfonamide era. International Journal of Cell Cloning . 1987 被引量:1
  • 9刘忠民,寿楠海,姜希宏.多药耐药相关蛋白在大肠癌中的表达及其临床意义[J].世界华人消化杂志,1999,7(11):1000-1001. 被引量:13

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部